Xwell (XWEL) Liabilities and Shareholders Equity (2010 - 2026)
Xwell (XWEL) posted Liabilities and Shareholders Equity of $25.0 million for Q1 2026, up 122.8% sequentially from $11.2 million in Q4 2025, and up 0.66% YoY from $24.8 million in Q1 2025.
Xwell (XWEL) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Xwell has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $25.0 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 0.66% year-over-year to $25.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.4 million (down 33.14% YoY) and the FY2025 annual result came in at $11.2 million, down 55.75% from the prior year.
- Liabilities and Shareholders Equity climbed to $25.0 million in Q1 2026 per XWEL's latest filing, from $11.2 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $101.4 million in Q2 2022 and troughed at $11.2 million in Q4 2025.
- A 5-year average of $45.1 million and a median of $37.5 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity slumped 55.75% in 2025, then grew 0.66% in 2026.
- Over 5 years, Liabilities and Shareholders Equity stood at $70.4 million in 2022, then slumped by 44.63% to $39.0 million in 2023, then plunged by 34.98% to $25.4 million in 2024, then tumbled by 55.75% to $11.2 million in 2025, then jumped by 122.8% to $25.0 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $25.0 million, $11.2 million, and $21.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 113.17 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 92.37 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 3.44 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 13.07 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 29.88 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.65 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.67 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 16.94 Bn |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | 24.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.99 Mn |
| Dec 31, 2025 | 11.22 Mn |
| Sep 30, 2025 | 21.74 Mn |
| Jun 30, 2025 | 22.45 Mn |
| Mar 31, 2025 | 24.83 Mn |
| Dec 31, 2024 | 25.35 Mn |
| Sep 30, 2024 | 33.79 Mn |
| Jun 30, 2024 | 36.29 Mn |
| Mar 31, 2024 | 37.48 Mn |
| Dec 31, 2023 | 38.99 Mn |
| Sep 30, 2023 | 42.94 Mn |
| Jun 30, 2023 | 56.59 Mn |
| Mar 31, 2023 | 62.60 Mn |
| Dec 31, 2022 | 70.43 Mn |
| Sep 30, 2022 | 84.98 Mn |
| Jun 30, 2022 | 101.37 Mn |
| Mar 31, 2022 | 70.43 Mn |
| Dec 31, 2021 | 127.27 Mn |
| Sep 30, 2021 | 129.28 Mn |
| Jun 30, 2021 | 120.12 Mn |